Vitamin D Deficiency in Patients Receiving Antidepressant Medications

1. Rosenblat JD, Gregory JM, Carvalho AF, McIntyre RS. Depression and disturbed bone metabolism: a narrative review of the epidemiological findings and postulated mechanisms. Curr Mol Med 2016; 16(2): 165-78.10.2174/1566524016666160126144303 Search in Google Scholar

2. Cizza G, Primma S, Coyle M, Gourgiotis L, Csako G. Depression and osteoporosis: a research synthesis with meta-analysis. Horm Metab Res 2010; 42(7): 467-82.10.1055/s-0030-1252020 Search in Google Scholar

3. Qiu L, Yang Q, Sun N, Li D, Zhao Y, Li X, et al. Association between depression and the risk for fracture: a meta-analysis and systematic review. BMC Psychiatry 2018; 18(1): 336.10.1186/s12888-018-1909-2 Search in Google Scholar

4. Shi TT, Min M, Zhang Y, Sun CY, Liang MM, Sun YH. Depression and risk of hip fracture: a systematic review and meta-analysis of cohort studies. Osteoporos Int 2019; 30(6): 1157-65.10.1007/s00198-019-04951-6 Search in Google Scholar

5. Van de Ven LI, Klop C, Overbeek JA, De Vries F, Burden AM, Janssen PK. Association between use of antidepressants or benzodiazepines and the risk of subsequent fracture among those aged 65+ in the Netherlands. Osteoporos Int 2018; 29(11): 2477-85.10.1007/s00198-018-4632-4 Search in Google Scholar

6. Calarge CA, Mills JA, Janz KF, Burns TL, Schlechte JA, Coryell WH, et al. The Effect of Depression, Generalized Anxiety, and Selective Serotonin reuptake Inhibitors on Change in Bone Metabolism in Adolescents and Emerging Adults. J Bone Miner Res 2017; 32(12): 2367-74.10.1002/jbmr.3238 Search in Google Scholar

7. Anderson PH. Vitamin D Activity and Metabolism in Bone. Curr Osteoporos Rep 2017; 15(5): 443-9.10.1007/s11914-017-0394-8 Search in Google Scholar

8. Lo Cascio V, Adami S, Tartarotti D, Ferrari S, Zatti M. Aberration in vitamin D metabolism during mianserin treatment. Lancet 1984; 1(8383): 958-9.10.1016/S0140-6736(84)92410-3 Search in Google Scholar

9. Oude Voshaar RC, Derks WJ, Comijs HC, Schoevers RA, De Borst MH, Marijnissen RM. Antidepressants differentially related to 1,25-(OH)₂ vitamin D₃ and 25- (OH) vitamin D₃ in late-life depression. Transl Psychiatry 2014; 4(4): e383.10.1038/tp.2014.14401227924736799 Search in Google Scholar

10. Stanojević Pirković M. Risk factors for disturbances of bone tissue homeostasis in patients with psychotic disorders, Ph.D. Thesis. Faculty of the Medical Sciences University of Kragujevac, Kragujevac (in Serbian), 2012. Search in Google Scholar

11. Milovanovic D. Population pharmacokinetics of 25- hydroxyvitamin D in students, Ph.D. Thesis, Faculty of Medical Sciences University of Kragujevac, Kragujevac (in Serbian) 2014. Search in Google Scholar

12. Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, et al. Endocrine Society: Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2011; 96(7): 1911-30.10.1210/jc.2011-038521646368 Search in Google Scholar

13. Anglin RE, Samaan Z, Walter SD, McDonald SD. Vitamin D deficiency and depression in adults: systematic review and meta-analysis. Br J Psychiatry 2013; 202: 100-7.10.1192/bjp.bp.111.10666623377209 Search in Google Scholar

14. Menon V, Kar SK, Suthar N, Nebhinani N. Vitamin D and Depression: A Critical Appraisal of the Evidence and Future Directions. Indian J Psychol Med 2020; 42(1): 11-21.10.4103/IJPSYM.IJPSYM_160_19697030031997861 Search in Google Scholar

15. Woo YS, Kim S, Jeong JH, Jung YE, Kim MD, Bahk WM. Vitamin D Deficiency/Insufficiency among Inpatients with Depressive Symptoms. Clin Psychopharmacol Neurosci 2019; 17(1): 121-24.10.9758/cpn.2019.17.1.121636104730690947 Search in Google Scholar

16. Bersani FS, Ghezzi F, Maraone A, Vicinanza R, Cavaggioni G, Biondi M, et al. The relationship between Vitamin D and depressive disorders. Riv Psichiatr 2019; 54(6): 229-34. Search in Google Scholar

17. Briggs R, McCarroll K, O’Halloran A, Healy M, Kenny RA, Laird E. Vitamin D Deficiency Is Associated With an Increased Likelihood of Incident Depression in Community-Dwelling Older Adults. J Am Med Dir Assoc 2019; 20(5): 517-23.10.1016/j.jamda.2018.10.00630470577 Search in Google Scholar

18. Spedding S. Vitamin D and depression: a systematic review and meta-analysis comparing studies with and without biological flaws. Nutrients 2014; 6(4): 1501-18.10.3390/nu6041501401104824732019 Search in Google Scholar

19. Anjum I, Jaffery SS, Fayyaz M, Samoo Z, Anjum S. The role of vitamin D in brain health: A Mini Literature Review. Cureus 2018; 10(7): e2960.10.7759/cureus.2960613268130214848 Search in Google Scholar

20. IOM (Institute of Medicine): Dietary reference intakes for calcium and vitamin D. The National Academies Press, Washington, DC, 2011. Search in Google Scholar

21. Caraci F, Calabrese F, Molteni R, Bartova L, Dold M, Leggio GM, et al. International Union of Basic and Clinical Pharmacology CIV: The Neurobiology of Treatment-resistant Depression: From Antidepressant Classifications to Novel Pharmacological Targets. Pharmacol Rev 2018; 70(3): 475-504.10.1124/pr.117.01497729884653 Search in Google Scholar

22. Ham AC, Aarts N, Noordam R, Rivadeneira F, Ziere G, Zillikens MC, et al. Use of Selective Serotonin Reuptake Inhibitors and Bone Mineral Density Change: A Population-Based Longitudinal Study in Middle-Aged and Elderly Individuals. J Clin Psychopharmacol 2017; 37(5): 524-30.10.1097/JCP.000000000000075628816927 Search in Google Scholar

23. Gustafsson BI, Thommesen L, Stunes AK, Tommeras K, Westbroek I, Waldum HL, et al. Serotonin and fluoxetine modulate bone cell function in vitro. J Cell Biochem 2006; 98(1): 139-51.10.1002/jcb.2073416408289 Search in Google Scholar

24. Fraher D, Hodge JM, Collier FM, McMillan JS, Kennedy RL, Ellis M, et al. Citalopram and sertraline exposure compromises embryonic bone development. Mol Psychiatry 2016; 21(5): 656-6410.1038/mp.2015.13526347317 Search in Google Scholar